Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Grand House Mulia Tbk. (HOMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Grand House Mulia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B), while Grand House Mulia Tbk. trades at Rp183 (market cap 288.23B). The key difference: Diagnos Laboratorium Utama Tbk. and Grand House Mulia Tbk. are close in size by market cap. Which is the better fit depends on your goals.
| DGNS | HOMI | |
|---|---|---|
Market Cap | 308B | 288.23B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Grand House Mulia Tbk.
PT Grand House Mulia, Tbk (“the Company”) was established in Republic of Indonesia based on the Notarial Deed No. 1 dated January 9, 2006 of Suryati Moerwibowo, S.H., The Company has commercially operated in April 2019.
Read more on HOMI →
